Trial Profile
A study to investigate CB1
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 25 May 2016
Price :
$35
*
At a glance
- Drugs CB 1 (Primary)
- Indications Breast cancer
- Focus Adverse reactions
- 19 May 2016 The Company is preparing the IND package with the intention of progressing to clinical trials this year, according to a Tiziana Life Sciences media release.
- 28 Jan 2016 New trial record
- 08 Jan 2016 The company intends to file an IND application on CB1 in 2016, and expects to move this drug candidate into clinical trials before the end of the year, according to a Tiziana Life Sciences media release.